Literature DB >> 24687521

Challenges for the development of bone-forming agents in Europe.

John A Kanis1, Rene Rizzoli, Cyrus Cooper, Jean-Yves Reginster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24687521     DOI： 10.1007/s00223-014-9844-9

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  7 in total

Review 1.  UK clinical guideline for the prevention and treatment of osteoporosis.

Authors:  Celia L Gregson; David J Armstrong; Jean Bowden; Cyrus Cooper; John Edwards; Neil J L Gittoes; Nicholas Harvey; John Kanis; Sarah Leyland; Rebecca Low; Eugene McCloskey; Katie Moss; Jane Parker; Zoe Paskins; Kenneth Poole; David M Reid; Mike Stone; Julia Thomson; Nic Vine; Juliet Compston
Journal:  Arch Osteoporos       Date:  2022-04-05       Impact factor: 2.879

2.  A Comprehensive Fracture Prevention Strategy in Older Adults: The European Union Geriatric Medicine Society (EUGMS) Statement.

Authors:  H Blain; T Masud; P Dargent-Molina; F C Martin; E Rosendahl; N van der Velde; J Bousquet; A Benetos; C Cooper; J A Kanis; J Y Reginster; R Rizzoli; B Cortet; M Barbagallo; K E Dreinhöfer; B Vellas; S Maggi; T Strandberg
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

3.  Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.

Authors:  J A Kanis; C Cooper; R Rizzoli; B Abrahamsen; N M Al-Daghri; M L Brandi; J Cannata-Andia; B Cortet; H P Dimai; S Ferrari; P Hadji; N C Harvey; M Kraenzlin; A Kurth; E McCloskey; S Minisola; T Thomas; J-Y Reginster
Journal:  Osteoporos Int       Date:  2017-04-27       Impact factor: 4.507

4.  Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide.

Authors:  Jean-Yves Reginster; Gary Hattersley; Gregory C Williams; Ming-Yi Hu; Lorraine A Fitzpatrick; E Michael Lewiecki
Journal:  Calcif Tissue Int       Date:  2018-06-27       Impact factor: 4.333

5.  Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.

Authors:  J A Kanis; N C Harvey; E McCloskey; O Bruyère; N Veronese; M Lorentzon; C Cooper; R Rizzoli; G Adib; N Al-Daghri; C Campusano; M Chandran; B Dawson-Hughes; K Javaid; F Jiwa; H Johansson; J K Lee; E Liu; D Messina; O Mkinsi; D Pinto; D Prieto-Alhambra; K Saag; W Xia; L Zakraoui; J -Y Reginster
Journal:  Osteoporos Int       Date:  2019-11-13       Impact factor: 4.507

Review 6.  Review of the guideline of the American College of Physicians on the treatment of osteoporosis.

Authors:  J A Kanis; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2018-06-04       Impact factor: 4.507

7.  Bone mineral content and areal density, but not bone area, predict an incident fracture risk: a comparative study in a UK prospective cohort.

Authors:  E M Curtis; N C Harvey; S D'Angelo; C S Cooper; K A Ward; P Taylor; G Pearson; C Cooper
Journal:  Arch Osteoporos       Date:  2016-12-03       Impact factor: 2.617
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.